Biotechnology
Europe’s pharma industry braces for tariffs as carve-out hopes fade
SEIZED OZEMPIC, WEGOVY AND OTHER WEIGHT LOSS DRUGS AT JFK AIRPORT’S INTERNATIONAL MAIL FACILITY. CNBC COPENHAGEN, Denmark — Europe’s pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by U.S. President Donald Trump fade. The pharmaceutical industry has until now been exempt from trade levies, but Trump […]
Read More
Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years
Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with diabetes and heart disease. The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to a placebo after four […]
Read More
Top FDA vaccine official Peter Marks resigns in opposition to RFK Jr.
Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration answers a question during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to COVID-19, at the U.S. Capitol in Washington, D.C., May 11, 2021. Greg Nash | Pool | Reuters […]
Read More
Novo Nordisk defends disappointing next-gen obesity drug: ‘It will be an important product’
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters Copenhagen, DENMARK — Novo Nordisk defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment. CEO […]
Read More
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Copenhagen, DENMARK — Obesity drug giant Novo Nordisk […]
Read More
Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Patients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market. Eli Lilly plans to […]
Read More
Novo Nordisk’s next-gen obesity drug CagriSema had investors excited. Now they’re not so sure
Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Novo Nordisk‘s hopes of heralding a new era of obesity treatment with its CagriSema drug have been called into question after a series of trial results sent shares falling. Headline results from […]
Read More
White House pulls Trump’s nomination for CDC director hours before confirmation hearing
Former Congressman Dave Weldon addresses a small crowd in The Villages, Fla. Brendan Farrington | AP The White House has pulled President Donald Trump’s nominee to lead the Centers for Disease Control and Prevention, former Rep. Dave Weldon, the Senate’s Health committee confirmed Thursday. The move came just hours before the former Florida lawmaker, a […]
Read More
Roche shares pop 4% on $5.3 billion obesity drug deal with Zealand Pharma
Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Danish biotech Zealand Pharma’s obesity drug candidate, as the two firms seek to compete in the burgeoning weight loss drug market. The deal will see the two companies co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as […]
Read More
RFK Jr. could further deter childhood vaccinations as rates fall in the U.S.
Robert F. Kennedy Jr. speaks in the Oval Office of the White House, on the day he is sworn in as secretary of Health and Human Service in Washington, D.C., U.S., Feb. 13, 2025. Nathan Howard | Reuters The nation’s new top health official could further erode already falling U.S. vaccination rates against once-common childhood […]
Read More